Clinical TrialsSearch results
Number of results: 406
Other
- Phase III randomized comparative study of combination therapy with CDDP and TS-1 vs. combination therapy with CDDP and Docetaxel in stage IIIB/IV non-small cell lung cancer
- Stage IIIB/IV or ppstoperative recurrent non-small sell lung cancer
- The Tokyo cooperative oncology group
- 2007-04-01
Other
- Phase II Study of Thymomectomy for Thymoma Localized in the Thymus
- thymoma
- Japanese Association for Research on the Thymus
- 2007-04-01
Other
- randomized trial for the efficacy of primary prophylaxis with granulocyte colony stimulating factor in advanced childhood mature B-cell malignancies
- advanced childhood mature B-cell malignancies
- Japan Pediatric Leukemia/Lymphoma Study Group
- 2007-04-11
Other
- Specimen Aquisition Program and Genetic Analysis for Myelodysplastic Syndromes
- Myelodysplastic Syndromes
- Keio University School of Medicine
- 2007-04-28
Other
- Registration Program for Myelodysplastic Syndromes and Aplastic Anemia
- Myelodysplastic Syndromes Aplastic Anemia
- Keio University School of Medicine
- 2007-04-28
Other
- Efficacy and Safety of mizoribine for MPO-ANCA associated vasculitis; A multicenter randomized controlled trial (Mizoribin for ANCA RPGN Relapse-Prevention study:MARPGN study)
- MPO-ANCA associated vasculitis
- Department of Nephrology, Division of Clinical Sciences, Faculty of Medicine, University of Tsukuba
- 2007-05-06
Other
- Phase II study of SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- extranodal NK/T-cell lymphoma, nasal type
- NK-cell Tumor Study Group
- 2007-05-14
Other
- A combination of prednisolone and mizoribine and a combination of prednisolone, mizoribine, warfarin and dipyridamole for IgA nephropathy with diffuse mesangial prolideration in children:A randomized controlled trial of efficacy and safety
- IgA nephropathy in children
- The Japanese Pediatric IgA Nephropathy of Treatment Study Group
- 2007-05-14
Other
- A Phase III Randomized, Multicenter Study Comparing Irinotevan and Cisplatin (IP) with Amrubicin and Cisplatin (AP) for the Treatment of Extensive-Stage Small-Cell Lung Cancer: (JCOG0509)
- extensive-disease small cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2007-05-22
Other
- Stanford type B aortic dissection patients with normally hypotensive medical therapy and pitavastatin treatment effect.
- Stanford type B acute aortic dissection patients transported within 48 hours of symptom onset , adaptable normally hypotensive medical therapy.
- Cardiovascular Surgery, Tohoku University, Graduate School of Medicine
- 2007-06-01